应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
IGA IGA基金
交易中 01-13 13:33:33 EST
9.81
-0.03
-0.30%
最高
9.85
最低
9.79
成交量
6.79万
今开
9.81
昨收
9.84
日振幅
0.61%
总市值
1.50亿
流通市值
1.50亿
总股本
1,534万
成交额
66.68万
换手率
0.44%
流通股本
1,534万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
海思科的“立项新声”：一款药唯有全球领先，才有出海可能
每日经济新闻 · 2024-09-30
海思科的“立项新声”：一款药唯有全球领先，才有出海可能
首个国产 IL-4R 单抗获批上市 ！
华尔街见闻 · 2024-09-12
首个国产 IL-4R 单抗获批上市 ！
加载更多
公司概况
公司名称：
IGA基金
所属市场：
NYSE
上市日期：
--
主营业务：
Voya Global Advantage & Premium Opportunity Fund是一家多元化的封闭式管理投资公司，根据1940年修订的《投资公司法》（"1940年法案"）注册。该基金组织为特拉华州法定信托。
发行价格：
--
{"stockData":{"symbol":"IGA","market":"US","secType":"STK","nameCN":"IGA基金","latestPrice":9.81,"timestamp":1768329075899,"preClose":9.84,"halted":0,"volume":67877,"delay":0,"floatShares":15341392,"shares":15341392,"eps":1.173593,"marketStatus":"交易中","change":-0.03,"latestTime":"01-13 13:33:33 EST","open":9.8085,"high":9.85,"low":9.79,"amount":666826.838219,"amplitude":0.006098,"askPrice":9.83,"askSize":100,"bidPrice":9.79,"bidSize":393,"shortable":3,"etf":1,"ttmEps":1.173593,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1768338000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":9.84,"aum":0,"dividendRate":0.103945,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":9.84,"preClose":9.84,"latestTime":"17:37 EST","volume":12,"amount":118.26,"timestamp":1768257439983},"volumeRatio":1.812325},"requestUrl":"/m/hq/s/IGA","defaultTab":"news","newsList":[{"id":"2471878694","title":"海思科的“立项新声”：一款药唯有全球领先，才有出海可能","url":"https://stock-news.laohu8.com/highlight/detail?id=2471878694","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471878694?lang=zh_cn&edition=full","pubTime":"2024-09-30 16:22","pubTimestamp":1727684554,"startTime":"0","endTime":"0","summary":"每经记者：陈星 每经编辑：董兴生近年来，随着国家政策的大力支持，中国创新药产业迎来蓬勃发展。在繁荣背后，“内卷”、同质化竞争等现象也“如约而至”。而在一众从仿制药转型创新药研发的传统制药企业中，成都企业海思科（002653.SZ，股价36.96元，市值411.78亿元）凭借其差异化的新药研发思路，在格局固化的麻醉...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/Oj0DLPIA3KFXJrHIszIfSZaH5F-KutOqQmo8VWaO3WhSsAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/Oj0DLPIA3KFXJrHIszIfSZaH5F-KutOqQmo8VWaO3WhSsAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240930A05TOP00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240930A05TOP00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["06978","IGA","BK1161","BK1574"],"gpt_icon":0},{"id":"2466065275","title":"首个国产 IL-4R 单抗获批上市 ！","url":"https://stock-news.laohu8.com/highlight/detail?id=2466065275","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466065275?lang=zh_cn&edition=full","pubTime":"2024-09-12 19:24","pubTimestamp":1726140255,"startTime":"0","endTime":"0","summary":"今日，康诺亚司普奇拜单抗获批上市，这是国产首款获批的 IL-4R 抗体药物，也是全球第二款。用于治疗外用药控制不佳或不适合外用药治疗的成人中重度特应性皮炎。","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/c084219d-4471-4755-b3f3-51488e2cfb99.png","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/c084219d-4471-4755-b3f3-51488e2cfb99.png"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3727820","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3727820","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["IGA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.voya.com","stockEarnings":[{"period":"1week","weight":0.0072},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.001},{"period":"6month","weight":0.0103},{"period":"1year","weight":0.0696},{"period":"ytd","weight":0.0123}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Voya Global Advantage & Premium Opportunity Fund是一家多元化的封闭式管理投资公司，根据1940年修订的《投资公司法》（\"1940年法案\"）注册。该基金组织为特拉华州法定信托。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.005083},{"month":2,"riseRate":0.6,"avgChangeRate":0.000991},{"month":3,"riseRate":0.8,"avgChangeRate":0.017216},{"month":4,"riseRate":0.35,"avgChangeRate":-0.007546},{"month":5,"riseRate":0.6,"avgChangeRate":0.003328},{"month":6,"riseRate":0.7,"avgChangeRate":0.002925},{"month":7,"riseRate":0.4,"avgChangeRate":-0.014451},{"month":8,"riseRate":0.7,"avgChangeRate":0.005973},{"month":9,"riseRate":0.45,"avgChangeRate":-0.007439},{"month":10,"riseRate":0.35,"avgChangeRate":-0.029549},{"month":11,"riseRate":0.761905,"avgChangeRate":0.005377},{"month":12,"riseRate":0.47619,"avgChangeRate":-0.004303}],"exchange":"NYSE","name":"IGA基金","nameEN":"Voya Global Advantage and Premium Opportunity Fund"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IGA基金(IGA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供IGA基金(IGA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"IGA基金,IGA,IGA基金股票,IGA基金股票老虎,IGA基金股票老虎国际,IGA基金行情,IGA基金股票行情,IGA基金股价,IGA基金股市,IGA基金股票价格,IGA基金股票交易,IGA基金股票购买,IGA基金股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IGA基金(IGA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供IGA基金(IGA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}